These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22802622)

  • 1. Unexpected role for MHC II-peptide complexes in shaping CD8 T-cell expansion and differentiation in vivo.
    Do JS; Valujskikh A; Vignali DA; Fairchild RL; Min B
    Proc Natl Acad Sci U S A; 2012 Jul; 109(31):12698-703. PubMed ID: 22802622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analyzing expression of perforin, Runx3, and Thpok genes during positive selection reveals activation of CD8-differentiation programs by MHC II-signaled thymocytes.
    Liu X; Taylor BJ; Sun G; Bosselut R
    J Immunol; 2005 Oct; 175(7):4465-74. PubMed ID: 16177089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice.
    Henderson SC; Berezovskaya A; English A; Palliser D; Rock KL; Bamezai A
    J Immunol; 1998 Jul; 161(1):175-82. PubMed ID: 9647222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-positive selection of thymocytes expressing a single TCR by multiple major histocompatibility complex molecules of both classes: implications for CD4+ versus CD8+ lineage commitment.
    Eshima K; Suzuki H; Shinohara N
    J Immunol; 2006 Feb; 176(3):1628-36. PubMed ID: 16424192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonist peptide selects thymocytes expressing a class II major histocompatibility complex-restricted T cell receptor into the CD8 lineage.
    Volkmann A; Barthlott T; Weiss S; Frank R; Stockinger B
    J Exp Med; 1998 Sep; 188(6):1083-9. PubMed ID: 9743527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
    Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
    Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of lymphatic endothelial cells expressing peripheral tissue antigens in CD4 T-cell tolerance induction.
    Rouhani SJ; Eccles JD; Riccardi P; Peske JD; Tewalt EF; Cohen JN; Liblau R; Mäkinen T; Engelhard VH
    Nat Commun; 2015 Apr; 6():6771. PubMed ID: 25857745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of MHC class I-stimulated alloresponses by TNF/TNF receptor (TNFR)1 interactions and of MHC class II-stimulated alloresponses by TNF/TNFR2 interactions.
    Brown GR; Thiele DL
    Eur J Immunol; 2000 Oct; 30(10):2900-7. PubMed ID: 11069072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo treatment of class II MHC-deficient mice with anti-TCR antibody restores the generation of circulating CD4 T cells and optimal architecture of thymic medulla.
    Nasreen M; Ueno T; Saito F; Takahama Y
    J Immunol; 2003 Oct; 171(7):3394-400. PubMed ID: 14500633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival and homeostatic proliferation of naive peripheral CD4+ T cells in the absence of self peptide:MHC complexes.
    Clarke SR; Rudensky AY
    J Immunol; 2000 Sep; 165(5):2458-64. PubMed ID: 10946271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for accessibility to self-peptide-self-MHC complexes in intrathymic negative selection.
    Viret C; Sant'Angelo DB; He X; Ramaswamy H; Janeway CA
    J Immunol; 2001 Apr; 166(7):4429-37. PubMed ID: 11254698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stage-dependent reactivity of thymocytes to self-peptide--MHC complexes.
    Leng Q; Ge Q; Nguyen T; Eisen HN; Chen J
    Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5038-43. PubMed ID: 17360333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCR7 expression in developing thymocytes is linked to the CD4 versus CD8 lineage decision.
    Yin X; Ladi E; Chan SW; Li O; Killeen N; Kappes DJ; Robey EA
    J Immunol; 2007 Dec; 179(11):7358-64. PubMed ID: 18025179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MHC class II transactivator is an in vivo regulator of osteoclast differentiation and bone homeostasis co-opted from adaptive immunity.
    Benasciutti E; Mariani E; Oliva L; Scolari M; Perilli E; Barras E; Milan E; Orfanelli U; Fazzalari NL; Campana L; Capobianco A; Otten L; Particelli F; Acha-Orbea H; Baruffaldi F; Faccio R; Sitia R; Reith W; Cenci S
    J Bone Miner Res; 2014 Feb; 29(2):290-303. PubMed ID: 24038328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of CD70 on dendritic cells through CD40 or TLR stimulation contributes to the development of CD8+ T cell responses in the absence of CD4+ T cells.
    Bullock TN; Yagita H
    J Immunol; 2005 Jan; 174(2):710-7. PubMed ID: 15634890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 T cells that are essential contributors to type 1 diabetes development in nonobese diabetic mice.
    Serreze DV; Holl TM; Marron MP; Graser RT; Johnson EA; Choisy-Rossi C; Slattery RM; Lieberman SM; DiLorenzo TP
    J Immunol; 2004 Jan; 172(2):871-9. PubMed ID: 14707058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional adaptive CD4 Foxp3 T cells develop in MHC class II-deficient mice.
    Bochtler P; Wahl C; Schirmbeck R; Reimann J
    J Immunol; 2006 Dec; 177(12):8307-14. PubMed ID: 17142726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel CD8 T cell alloreactivities in CCR5-deficient recipients of class II MHC disparate kidney grafts.
    Ishii D; Rosenblum JM; Nozaki T; Schenk AD; Setoguchi K; Su CA; Gorbacheva V; Baldwin WM; Valujskikh A; Fairchild RL
    J Immunol; 2014 Oct; 193(7):3816-24. PubMed ID: 25172484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutting edge: negative selection of immature thymocytes by a few peptide-MHC complexes: differential sensitivity of immature and mature T cells.
    Peterson DA; DiPaolo RJ; Kanagawa O; Unanue ER
    J Immunol; 1999 Mar; 162(6):3117-20. PubMed ID: 10092759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-specific MHC class II-restricted CD4-CD8- T cells that escape deletion and lack regulatory activity.
    Viret C; Janeway CA
    J Immunol; 2003 Jan; 170(1):201-9. PubMed ID: 12496401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.